Abstract
Impairment of the health-related quality of life (HRQOL) of patients with end-stage renal disease (ESRD) is now well documented. These impairments involve a wide variety of domains and can be assessed using an array of well-validated instruments. Incorporation of at least some of these instruments into routine patient care is important in order to measure the physical and psychological impact of a disease and its treatment on the HRQOL of patients. How this implementation can be achieved in a practical way is, however, a challenge. As more research focuses on improving the HRQOL of patients with ESRD, the systematic evaluation of HRQOL and incorporation into patient care is becoming increasingly important. Whether strategies to improve the HRQOL of patients will translate into improved patient outcomes—as evidenced by reduced mortality and hospitalizations—and lower costs, remains to be determined.
Key Points
-
The assessment of health-related quality of life provides important information about patients with end-stage renal disease (ESRD)
-
Routine assessment of patient-reported outcomes (PROs) should be incorporated into the standard care of patients with ESRD
-
Improvements in PROs can result from various interventions, such as treatment of depression and alterations in the dialysis therapy regimen
-
Whether treatment algorithms designed to improve PROs will reduce rates of mortality and hospitalization remains to be determined
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Finkelstein, F. O., Wuerth, D. & Finkelstein, S. H. Health related quality of life and the CKD patient: challenges for the nephrology community. Kidney Int. 76, 946–952 (2009).
Evans, R. W. et al. The quality of life of patients with end-stage renal disease. N. Engl. J. Med. 312, 553–559 (1985).
Boateng, E. A. & East, L. The impact of dialysis modality on quality of life: a systematic review. J. Ren. Care 37, 190–200 (2011).
Mucsi, I., Kovacs, A. Z., Molnar, M. Z. & Novak, M. Co-morbidity and quality of life in chronic kidney disease patients. J. Nephrol. 21 (Suppl. 13), S84–S91 (2008).
Glover, C., Banks, P., Carson, A., Martin, C. R. & Duffy, T. Understanding and assessing the impact of end-stage renal disease on quality of life: a systematic review of the content validity of self-administered instruments used to assess health-related quality of life in end-stage renal disease. Patient 4, 19–30 (2011).
Soni, R. K., Porter, A. C., Lash, J. P. & Unruh, M. L. Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions. Adv. Chronic Kidney Dis. 17, e17–e26 (2010).
Landreneau, K., Lee, K. & Landreneau, M. D. Quality of life in patients undergoing hemodialysis and renal transplantation—a meta-analytic review. Nephrol. Nurs. J. 37, 37–44 (2010).
Soni, R. K., Weisbord, S. D. & Unruh, M. L. Health-related quality of life outcomes in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 19, 153–159 (2010).
Germain, M. J. & Cohen, L. M. Maintaining quality of life at the end of life in the end-stage renal disease population. Adv. Chronic Kidney Dis. 15, 133–139 (2008).
Weisbord, S. D. & Kimmel, P. L. Health-related quality of life in the era of erythropoietin. Hemodial. Int. 12, 6–15 (2008).
Dale, P. L., Hutton, J. & Elgazzar, H. Utility of health states in chronic kidney disease: a structured review of the literature. Curr. Med. Res. Opin. 24, 193–206 (2008).
Clement, F. M., Klarenbach, S., Tonelli, M., Johnson, J. A. & Manns, B. J. The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis. Arch. Intern. Med. 169, 1104–1112 (2009).
Kimmel, P. L., Cohen, S. D. & Weisbord, S. D. Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough! J. Nephrol. 21 (Suppl. 13), S54–S58 (2008).
Unruh, M. L. & Hess, R. Assessment of health-related quality of life among patients with chronic kidney disease. Adv. Chronic Kidney Dis. 14, 345–352 (2007).
Korevaar, J. C. et al. Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual. Life Res. 11, 437–447 (2002).
Steele, T. E. et al. Sexual experience of the chronic peritoneal dialysis patient. J. Am. Soc. Nephrol. 7, 1165–1168 (1996).
Peng, Y. S. et al. Sexual dysfunction in female hemodialysis patients: a multicenter study. Kidney Int. 68, 760–765 (2005).
Türk, S. et al. Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin. Pract. 96, c21–c27 (2004).
Davison, S. N. The prevalence and management of chronic pain in end-stage renal disease. J. Palliat. Med. 10, 1277–1287 (2007).
Shayamsunder, A. K., Patel, S. S., Jain, V., Peterson, R. A. & Kimmel, P. L. Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patients. Semin. Dial. 18, 109–118 (2005).
Cohen, S. D. et al. Social support and chronic kidney disease: an update. Adv. Chronic Kidney Dis. 14, 335–344 (2007).
Steele, T. E., Finkelstein, S. H. & Finkelstein, F. O. Marital discord, sexual problems, and depression. J. Nerv. Ment. Dis. 162, 225–237 (1976).
Steidl, J. H. et al. Medical condition, adherence to treatment regimens, and family functioning. Their interactions in patients receiving long-term dialysis treatment. Arch. Gen. Psychiatry 37, 1025–1027 (1980).
Fukuhara, S., Yamazaki, S., Hayashino, Y. & Green, J. Measuring health-related quality of life in patients with end-stage renal disease: why and how. Nat. Clin. Pract. Nephrol. 3, 352–353 (2007).
Hedayati, S. S. et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 74, 930–936 (2008).
Hedayati, S. S. et al. Physician-diagnosed depression as a correlate of hospitalizations in patients receiving long-term hemodialysis. Am. J. Kidney Dis. 46, 642–649 (2005).
Lopes, A. A. et al. Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS. Kidney Int. 66, 2047–2053 (2004).
Lopes, A. A. et al. for the Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 62, 199–207 (2002).
Kutner, N. G., Zhang, R., Barnhart, H. & Collins, A. J. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol. Dial. Transplant. 20, 2159–2167 (2005).
Kutner, N. G. Quality of life and daily hemodialysis. Semin. Dial. 17, 92–98 (2004).
Mapes, D. L. et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 64, 339–349 (2003).
Wu, A. W. et al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measures. J. Am. Soc. Nephrol. 15, 743–753 (2004).
Kimmel, P. L., Emont, S. L., Newmann, J. M., Danko, H. & Moss, A. H. ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity. Am. J. Kidney Dis. 42, 713–721 (2003).
Kimmel, P. L. et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 57, 2093–2098 (2000).
Reynolds, J. T. et al. A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif. 22, 320–328 (2004).
Lacson, E. Jr et al. Depressive symptoms associate with high mortality risk and dialysis withdrawal in incident hemodialysis patients. Nephrol. Dial. Transplant. 27, 2921–2928 (2012).
Jaber, B. L. et al. on behalf of the FREEDOM Study Group. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin. J. Am. Soc. Nephrol. 6, 1049–1056 (2011).
Jaber, B. L. et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am. J. Kidney Dis. 56, 531–539 (2010).
Finkelstein, F. O. et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int. 82, 561–569 (2012).
Brown, E. A. Can quality of life be improved for the increasing numbers of older patients with end-stage kidney disease? Expert Rev. Pharmacoecon. Outcomes Res. 10, 661–666 (2010).
Kliger, A. S. & Finkelstein, F. O. Can we improve the quality of life for dialysis patients? Am. J. Kidney Dis. 54, 993–995 (2009).
Chertow, G. M. et al. In-center hemodialysis six times per week versus three times per week. N. Engl. J. Med. 363, 2287–2300 (2010).
Duarte, P. S., Miyazaki, M. C., Blay, S. L. & Sesso, R. Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int. 76, 414–421 (2009).
Painter, P. et al. Effects of exercise training plus normalization of hematocrit on exercise capacity and health-related quality of life. Am. J. Kidney Dis. 39, 257–265 (2002).
Suri, R. S. et al. for the Frequent Hemodialysis Network Trial Group. Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int. 71, 349–359 (2007).
U. S. Department of Health and Human Services. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims [online], (2009).
Jaber, B. L. et al. Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study. Am. J. Kidney Dis. 53, 310–320 (2009).
National Institutes of Health. PROMIS®: Dynamic tools to measure health outcomes from the patient perspective [online], (2012).
Patient-Centered Outcomes Research Institute. Patient-Centered Outcomes Research [online], (2012).
Kliger, A. S., Fishbane, S. & Finkelstein, F. O. Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment. Clin. J. Am. Soc. Nephrol. 7, 354–357 (2012).
Leaf, D. E. & Goldfarb, D. S. Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia. Kidney Int. 75, 15–24 (2009).
Johansen, K. L. et al. Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents. Am. J. Kidney Dis. 55, 535–548 (2010).
Gandra, S. R. et al. Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review. Am. J. Kidney Dis. 55, 519–534 (2010).
Weisbord, S. D. et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin. J. Am. Soc. Nephrol. 2, 960–967 (2007).
Brown, E. A. et al. Broadening options for long-term dialysis in the elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol. Dial. Transplant. 25, 3755–3763 (2010).
Paniagua, R., Amato, D., Vonesh, E., Guo, A. & Mujais, S. for the Mexican Nephrology Collaborative Study Group. Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: the ADEMEX trial. Kidney Int. 67, 1093–1104 (2005).
Balducci, L. Death and dying: what the patient wants. Ann. Oncol. 23 (Suppl. 3), 56–61 (2012).
Martino, S., Chwastiak, L. & Finkelstein, F. O. in Nutritional Management of Renal Disease 3rd edn (eds Kopple, J. D., Massry, S. G. & Kalanter-Zadeh, K.) (Academic Press, Philadelphia, 2012, in press).
Teutsch, C. Patient-doctor communication. Med. Clin. North Am. 87, 1115–1145 (2003).
Thong, M. S. et al. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am. J. Kidney Dis. 52, 111–117 (2008).
Cukor, D. et al. Anxiety disorders in adults treated by hemodialysis: a single-center study. Am. J. Kidney Dis. 52, 128–136 (2008).
Juergensen, E. et al. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin. J. Am. Soc. Nephrol. 1, 1191–1196 (2006).
Rubin, H. R. et al. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 291, 697–703 (2004).
Tong, A. et al. Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrol. Dial. Transplant. 23, 3206–3214 (2008).
Fadem, S. Z. et al. Satisfaction with renal replacement therapy and education: the American Association of Kidney Patients survey. Clin. J. Am. Soc. Nephrol. 6, 605–612 (2011).
Al Eissa, M. et al. Factors affecting hemodialysis patients' satisfaction with their dialysis therapy. Int. J. Nephrol. 2010, 342901 (2010).
Gayomali, C., Sutherland, S. & Finkelstein, F. O. The challenge for the caregiver of the patient with chronic kidney disease. Nephrol. Dial. Transplant. 23, 3749–3751 (2008).
Unruh, M. et al. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int. 66, 355–366 (2004).
Cullerton, B. et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298, 1291–1299 (2007).
Manns, B. J. et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int. 75, 542–549 (2009).
Unruh, M. L. et al. Effects of six versus three times per week hemodialysis on depressive affect and mental health: Frequent Hemodialysis Network (FHN) Trials [abstract]. J. Am. Soc. Nephrol. 22, TH-PO623 (2011).
Butt, Z., Yount, S. E., Caicedo, J. C., Abecassis, M. M. & Cella, D. Quality of life assessment in renal transplant: review and future directions. Clin. Transplant. 22, 292–303 (2008).
Dobbels, F., De Bleser, L., De Geest, S. & Fine, R. N. Quality of life after kidney transplantation: the bright side of life? Adv. Chronic Kidney Dis. 14, 370–378 (2007).
Maglakelidze, N., Pantsulaia, T., Tchokhonelidze, I., Managadze, L. & Chkhotua, A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant. Proc. 43, 376–379 (2011).
Bonney, S., Finkelstein, F. O., Lytton, B., Schiff, M. & Steele, T. E. Treatment of end-stage renal failure in a defined geographic area. Arch. Intern. Med. 138, 1510–1513 (1978).
Tonelli, M. et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am. J. Transplant. 11, 2093–2109 (2011).
Avramovic, M. & Stefanovic, V. Health-related quality of life in different stages of renal failure. Artif. Organs 36, 581–589 (2012).
Tong, A. et al. The motivations and experiences of living kidney donors: a thematic synthesis. Am. J. Kidney Dis. 60, 15–26 (2012).
United States Census Bureau [online], (2011).
United States Renal Data System. 2011 Annual Data Report [online], (2011).
Kadambi, P., Troidle, L., Gorban-Brennan, N., Kilger, A. S. & Finkelstein, F. O. APD in the elderly. Semin. Dial. 15, 430–433 (2002).
Davison, S. N. End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 195–204 (2010).
Brown, E. A. & Johansson, L. Epidemiology and management of end-stage renal disease in the elderly. Nat. Rev. Nephrol. 7, 591–598 (2011).
Dimkovic, N. & Oreopoulos, D. Management of elderly patients with end-stage kidney disease. Semin. Nephrol. 29, 643–649 (2009).
Schmidt, R. J. Informing our elders about dialysis: is an age-attuned approach warranted? Clin. J. Am. Soc. Nephrol. 7, 185–191 (2012).
Chandna, S. M. et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol. Dial. Transplant. 26, 1608–1614 (2011).
Murtagh, F. E. et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol. Dial. Transplant. 22, 1955–1962 (2007).
Peterson, R. A. et al. Depression, perception of illness and mortality in patients with end-stage renal disease. Int. J. Psychiatry Med. 21, 343–354 (1991).
Hedayati, S. S. & Finkelstein, F. O. Epidemiology, diagnosis, and management of depression in patients with CKD. Am. J. Kidney Dis. 54, 741–752 (2009).
Boulware, L. E. et al. Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality. Clin. J. Am. Soc. Nephrol. 1, 496–504 (2006).
Hedayati, S. S., Yalamanchili, V. & Finkelstein, F. O. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 81, 247–255 (2012).
Ouzouni, S., Kouidi, E., Sioulis, A., Grekas, D. & Deligiannis, A. Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin. Rehabil. 23, 53–63 (2009).
Levendog˘lu, F. et al. A twelve week exercise program improves the psychological status, quality of life and work capacity in hemodialysis patients. J. Nephrol. 17, 826–832 (2004).
Sprangers, M. A. et al. The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes. Twin Res. Hum. Genet. 12, 301–311 (2009).
Author information
Authors and Affiliations
Contributions
All authors contributed equally to discussion of content for the article, researching data to include in the manuscript, and reviewing and editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
F. Finkelstein is a consultant and has received grant or research support from Amjen. He is on the speakers bureau for Baxter and is a consultant for NxStage Medical. F. Finkelstein, K. L. Arsenault, A. Taveras and K. Awuah are affiliated with New Haven Home Dialysis, which is owned by Fresenius Medical Care.
Rights and permissions
About this article
Cite this article
Finkelstein, F., Arsenault, K., Taveras, A. et al. Assessing and improving the health-related quality of life of patients with ESRD. Nat Rev Nephrol 8, 718–724 (2012). https://doi.org/10.1038/nrneph.2012.238
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2012.238
This article is cited by
-
An Evidence-Based Theory About PRO Use in Kidney Care: A Realist Synthesis
The Patient - Patient-Centered Outcomes Research (2022)
-
Integrating a Medical Home in an Outpatient Dialysis Setting: Effects on Health-Related Quality of Life
Journal of General Internal Medicine (2019)
-
Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis
The European Journal of Health Economics (2019)
-
Methodological considerations in using patient reported measures in dialysis clinics
Journal of Patient-Reported Outcomes (2017)
-
Hyperparathyroidism in Hemodialysis Population of Patients in Various Age Groups
BioNanoScience (2016)